At the beginning of October, GN Hearing CEO Gitte Aabo downgraded the company's financial expectations for the full year, primarily referring to delays at its research and development division.
Difficulties continue, however, as restrictions on certain markets the across the globe still pose challenges.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Director Global Engineering 
Cell Culture Scientist/Senior Scientist 
IRT Manager, Clinical Drug Supply 
Communications Consultant 
Nordic Medical Affairs Manager 
Key Account Manager, Europe and Asia 
Clinical Project Manager 
(Senior) Drug Substance Specialist 
Senior IT Network Engineer 
Director of Toxicology 
Account Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Clinical Trial Manager for development of in vitro diagnostics 
Strategic Procurement Manager, Direct Spend (Category Manager) 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Senior Project Manager (GMP - Life Science)